Vir Biotechnology (VIR) Current Deferred Revenue (2018 - 2025)
Vir Biotechnology (VIR) posted Current Deferred Revenue of $10.11 million for Q2 2025, down 39.5% from $16.7 million a year earlier and down 15.3% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Current Deferred Revenue (2018 - 2025) Analysis & Trends
At the end of FY2024, Vir Biotechnology's Current Deferred Revenue came in at $12.65 million, down 80.5% from FY2023.
- Annual Current Deferred Revenue shows a five-year compound annual growth rate of 15.4% (FY2019 to FY2024).
- In prior years, Vir Biotechnology's Current Deferred Revenue was $64.85 million in FY2023 (+317.9%), $15.52 million in FY2022 (-84.2%), $98.21 million in FY2021 and $6.45 million in FY2020 (+4.4%).
- The Q2 2025 figure stands as the lowest quarterly Current Deferred Revenue since Q4 2020.
- On a year-over-year basis, Current Deferred Revenue has declined in each of the last four quarters, with growth averaging 17.2% over the last eight quarters.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q2 2021, with growth of 512.7%; the weakest was Q2 2023, with a decline of 86.1%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $11.94 million (Q1 2025), $12.65 million (Q4 2024) and $15.2 million (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Vir Biotechnology | 1.89 Bn | 1.89 Bn | 238.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 10.11 Mn |
| Mar 31, 2025 | 11.94 Mn |
| Dec 31, 2024 | 12.65 Mn |
| Sep 30, 2024 | 15.20 Mn |
| Jun 30, 2024 | 16.70 Mn |
| Mar 31, 2024 | 14.69 Mn |
| Dec 31, 2023 | 64.85 Mn |
| Sep 30, 2023 | 15.31 Mn |
| Jun 30, 2023 | 15.68 Mn |
| Mar 31, 2023 | 17.22 Mn |
| Dec 31, 2022 | 15.52 Mn |
| Sep 30, 2022 | 22.87 Mn |
| Jun 30, 2022 | 113.16 Mn |
| Mar 31, 2022 | 113.74 Mn |
| Dec 31, 2021 | 98.21 Mn |
| Sep 30, 2021 | 96.15 Mn |
| Jun 30, 2021 | 44.72 Mn |
| Mar 31, 2021 | 262.93 Mn |
| Dec 31, 2020 | 6.45 Mn |
| Sep 30, 2020 | 5.56 Mn |
API Access
Vir Biotechnology Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();